Results 51 to 60 of about 34,974 (164)

Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma. [PDF]

open access: yesOphthalmol Ther, 2022
This retrospective consecutive study compared standalone implantation of multiple (2-3) trabecular micro-bypass stents (iStent inject ± iStent) (Multi-Stent group) vs trabeculectomy + mitomycin C (Trab group) in moderate to severe open-angle glaucoma (OAG).Eligible patients underwent Multi-Stent or Trab surgery from 2018 to 2020 and had at least 3 ...
Paletta Guedes RA   +3 more
europepmc   +4 more sources

Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma [PDF]

open access: yesClinical & Experimental Ophthalmology, 2019
AbstractImportanceMinimally invasive glaucoma surgery has gained significant traction in recent years. This study evaluates the first‐ and second‐generation trabecular micro‐bypass stents “iStent” and “iStent inject”.BackgroundTo evaluate and compare the effect of a single iStent and double iStent inject in primary open angle glaucoma.DesignProspective
Joobin Hooshmand   +5 more
openaire   +3 more sources

PERMANENT DATABASE - Learning Curve Phaco+iStent

open access: yes, 2023
Learning-Curved of Phaco+iStent inject assessed through 6 surgeons in a teaching hospital (residents and consultants)
Rafael Correia Barão (11097858)   +2 more
core   +1 more source

Kahook Dual Blade Goniotomy vs iStent inject: Long-Term Results in Patients with Open-Angle Glaucoma

open access: yesClinical Ophthalmology, 2021
Thorsteinn S Arnljots,1 Mario A Economou2,3 1Anterior Segment Department, St. Erik Eye Hospital, Stockholm, Sweden; 2Division of Ophthalmology and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 3Department of ...
Arnljots TS, Economou MA
doaj  

Preliminary outcomes of cataract surgery with iStent inject® W [PDF]

open access: yesHiroshima Journal of Medical Sciences, 2023
This study was performed to investigate the preliminary outcomes and complications of patients with glaucoma who underwent cataract surgery with iStent inject® W implantation. The study involved 32 eyes of 27 patients (mean age, 69.2 ± 10.0 years) who underwent cataract surgery with an iStent inject® W from November 2020 to June 2021 at Kyorin ...
MOCHIZUKI, Tsukasa   +4 more
openaire   +1 more source

sj-docx-1-ejo-10.1177_11206721231190417 - Supplemental material for Novel surgical technique to manage iStent inject over-implantation

open access: yes, 2023
Supplemental material, sj-docx-1-ejo-10.1177_11206721231190417 for Novel surgical technique to manage iStent inject over-implantation by Bryan Chin Hou Ang and Elizabeth Jiahui Chen in European Journal of ...
Bryan Chin Hou Ang (9278408)   +1 more
core   +1 more source

Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery

open access: yesClinical Ophthalmology, 2021
Ricardo Augusto Paletta Guedes,1 Daniela Marcelo Gravina,1 Vanessa Maria Paletta Guedes,1 Alfredo Chaoubah2 1Glaucoma Department, Paletta Guedes Eye Institute, Juiz de Fora, MG, Brazil; 2Statistics Department, Federal University of Juiz De Fora, Juiz de ...
Paletta Guedes RA   +3 more
doaj  

Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy

open access: yesBMC Health Services Research, 2021
Background Glaucoma is a disease characterized by progressive damage of the optic nerve. Several therapeutic options are available to lower intraocular pressure (IOP).
Antonio Maria Fea   +5 more
doaj   +1 more source

Correction: Outcomes of iStent inject combined with cataract surgery in Asian eyes: Australian data from the Fight Glaucoma Blindness international registry. [PDF]

open access: yesInt Ophthalmol
PURPOSE: To analyse real-world outcomes in Asian eyes of iStent inject, a second-generation trabecular micro-bypass stent, combined with phacoemulsification.
Huynh B   +6 more
europepmc   +2 more sources

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy